Sign in
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma
Journal article   Peer reviewed

High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma

Daniel O Persky, Craig H Moskowitz, Alexander Filatov, Rakhee Saxena, Haiyan Cui and Julie Teruya-Feldstein
Applied immunohistochemistry & molecular morphology, Vol.18(1), pp.35-40
2010-01
PMID: 19701081

Abstract

Adolescent Adult Aged Apoptosis Regulatory Proteins - analysis Bcl-2-Like Protein 11 Biomarkers, Tumor - analysis Carboplatin - therapeutic use Combined Modality Therapy - methods Etoposide - therapeutic use Hematopoietic Stem Cell Transplantation - methods Hodgkin Disease - diagnosis Hodgkin Disease - mortality Hodgkin Disease - therapy Humans Ifosfamide - therapeutic use Immunohistochemistry Membrane Proteins - analysis Middle Aged Prognosis Proto-Oncogene Proteins - analysis Proto-Oncogene Proteins c-bcl-2 - analysis Salvage Therapy - methods Transplantation, Autologous Tumor Suppressor Protein p53 - analysis Young Adult

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.130 Lymphomas
1.130.132 Lymphoma
Web Of Science research areas
Anatomy & Morphology
Medical Laboratory Technology
Pathology
ESI research areas
Biology & Biochemistry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details